Salem Investment Counselors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Salem Investment Counselors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,200	Closed	-$39K	–	573
2018 Q1	$39K	Hold	17,200	–	–	﹤0.01%	321
2017 Q4	$51K	Hold	17,200	–	–	0.01%	311
2017 Q3	$51K	Hold	17,200	–	–	0.01%	304
2017 Q2	$48K	Hold	17,200	–	–	0.01%	321
2017 Q1	$33K	Hold	17,200	–	–	﹤0.01%	420
2016 Q4	$30K	Sell	17,200 -5,550	-24%	-$11.3K	﹤0.01%	406
2016 Q3	$614	Hold	22,750	–	–	0.01%	296
2016 Q2	$54K	Hold	22,750	–	–	0.01%	251
2016 Q1	$73K	Hold	22,750	–	–	0.01%	248
2015 Q4	$109K	Hold	22,750	–	–	0.01%	251
2015 Q3	$125K	Sell	22,750 -11,100	-33%	-$81.9K	0.02%	253
2015 Q2	$269K	Hold	33,850	–	–	0.03%	241
2015 Q1	$355K	Hold	33,850	–	–	0.04%	220
2014 Q4	$407K	Hold	33,850	–	–	0.05%	204
2014 Q3	$578K	Hold	33,850	–	–	0.07%	181
2014 Q2	$409K	Hold	33,850	–	–	0.05%	207
2014 Q1	$286K	Hold	33,850	–	–	0.04%	245
2013 Q4	$199K	Hold	33,850	–	–	0.03%	261
2013 Q3	$184K	Hold	33,850	–	–	0.03%	268
2013 Q2	$137K	Buy	+33,850	New	+$159K	0.02%	260

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Salem Investment Counselors's BDSI Position: Q2 2018 in Review

Salem Investment Counselors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2018, closing a stake of 17,200 shares — an estimated $39K sold.

Salem Investment Counselors first reported a position in BDSI in Q2 2013 and held it in 20 quarters. The position peaked at $578K in Q3 2014. 68 funds tracked by Wall St. Rank hold BDSI as of Q2 2018.

Salem Investment Counselors reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2018 after selling out during the quarter.
Salem Investment Counselors sold 17,200 BioDelivery Sciences International, Inc. shares in Q2 2018, an estimated $39K.
Salem Investment Counselors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 20 quarters.
Salem Investment Counselors's BioDelivery Sciences International, Inc. position peaked at $578K in Q3 2014.
68 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2018.

Based on Salem Investment Counselors's 13F filing for Q2 2018, filed 15 Aug 2018.